Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Social Determinants of Health, the developing brain, and risk and resilience for psychopathology
    Published on 2025-07-16
    1 year ago
  • Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study
    Published on 2025-07-15
    1 year ago
  • M6A RNA epitranscriptome dynamics linked to major depressive disorder and suicide risk
    Published on 2025-07-10
    1 year ago
  • Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum
    Published on 2025-07-10
    1 year ago
  • Microglia as critical mediators linking perinatal immune stress to mental health trajectories
    Published on 2025-07-09
    1 year ago
  • A biological blind spot in addiction research: hormonal contraceptives and adolescent reward seeking
    Published on 2025-07-09
    1 year ago
  • nNOS-expressing neurons in the mPFC mediate depression-related behaviors in mice through pPVT-mPFC projections
    Published on 2025-07-08
    1 year ago
« Previous 1 … 47 48 49 50 51 … 143 Next »
Journal of Psychopharmacology
  • Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study
    Published on 2024-06-18
    2 years ago
  • Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
    Published on 2024-06-18
    2 years ago
  • Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
    Published on 2024-06-15
    2 years ago
  • The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis
    Published on 2024-06-12
    2 years ago
  • Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
    Published on 2024-06-12
    2 years ago
  • Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities
    Published on 2024-06-10
    2 years ago
  • The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms
    Published on 2024-06-03
    2 years ago
« Previous 1 … 47 48 49 50 51 … 150 Next »
European Neuropsychopharmacology
  • Sex representation in mental health research
    Published on 2024-04-24
    2 years ago
  • Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
    Published on 2024-04-24
    2 years ago
  • Rare variants and clozapine: Reply
    Published on 2024-04-21
    2 years ago
  • Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic
    Published on 2024-04-21
    2 years ago
  • Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia
    Published on 2024-04-21
    2 years ago
  • Challenges in testing concentrated cognitive-behaviour therapy for unmedicated adults with obsessive-compulsive disorder in routine care
    Published on 2024-04-21
    2 years ago
  • Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents
    Published on 2024-04-21
    2 years ago
« Previous 1 … 47 48 49 50 51 … 168 Next »

 

Psychopharmacology
  • Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug
    Published on 2025-05-01
    1 year ago
  • Senegenin ameliorates diabetic encephalopathy via promoting mitophagy and repressing NLRP3 inflammasome activation
    Published on 2025-04-26
    1 year ago
  • Oxiracetam ameliorates neurological function after traumatic brain injury through competing endogenous RNA regulatory network
    Published on 2025-04-24
    1 year ago
  • Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs
    Published on 2025-04-23
    1 year ago
  • Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users
    Published on 2025-04-23
    1 year ago
  • The effect of nicotine on threat avoidance behaviour in healthy non-smokers
    Published on 2025-04-22
    1 year ago
  • Cognitive flexibility of male rats is increased by augmented punishment in a reversal learning task but ketamine has no detectable long-term effects
    Published on 2025-04-22
    1 year ago
« Previous 1 … 47 48 49 50 51 … 414 Next »
International Journal of Neuropsychopharmacology
  • 485. PSYCHIATRIC COMORBIDITY IN PATIENTS WITH TINNITUS OR AUDITORY HALLUCINATION AND SLEEP EVALUATION, SOUND THERAPY AND SHARED DECISION MAKING (SDM)
    Published on 2025-08-18
    11 months ago
  • 653. THE DEVELOPMENT OF DRUGS TO ACTIVATE THE MUSCARINIC M1 AND M4 RECEPTORS TO TREAT DISORDERS OF THE HUMAN CNS
    Published on 2025-08-18
    11 months ago
  • 689. FEASIBILITY AND PRELIMINARY EFFICACY OF N-ACETYLCYSTEINE FOR LOSS OF CONTROL EATING: AN OPEN LABEL STUDY
    Published on 2025-08-18
    11 months ago
  • 232. α6GABAA RECEPTOR-SELECTIVE POSITIVE ALLOSTERIC MODULATOR AS A POTENTIAL THERAPY FOR AUTISM: A PRECLINICAL STUDY IN FMR1 KO MICE
    Published on 2025-08-18
    11 months ago
  • 612. EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A POOLED ANALYSIS OF PHASE 3 RANDOMIZED CONTROLLED TRIALS
    Published on 2025-08-18
    11 months ago
  • 177. A GENETICALLY INFORMED APPROACH TO ANTIDEPRESSANT PRESCRIPTION FOR YOUTH WITH MAJOR DEPRESSIVE DISORDER
    Published on 2025-08-18
    11 months ago
  • 665. CELLULAR MECHANISMS OF NICOTINE CRAVING
    Published on 2025-08-18
    11 months ago
« Previous 1 … 47 48 49 50 51 … 237 Next »
Frontiers in Pharmacology
  • Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy
    Published on 2025-07-22
    1 year ago
  • Preclinical pharmacology of alogabat: a novel GABAA-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABAA signaling
    Published on 2025-07-21
    1 year ago
  • Pharmacogenetics or predictive genetics? APOE testing blurs the lines
    Published on 2025-07-21
    1 year ago
  • Correction: The antipsychotics functional index (AFI) in schizophrenia
    Published on 2025-07-18
    1 year ago
  • Several endocannabinoids and amino acids may be biosynthetically converted to catecholamines in vivo
    Published on 2025-07-18
    1 year ago
  • Genetic implication of GABAB receptors in the etiology of neurological and psychiatric disorders
    Published on 2025-07-18
    1 year ago
  • Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders
    Published on 2025-07-16
    1 year ago
« Previous 1 … 47 48 49 50 51 … 276 Next »

 

Translational Psychiatry
  • SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study
    Published on 2026-03-23
    4 months ago
  • Prediction of depressive episodes based on clinical features, cognitive characteristics, inflammation-related proteins, and EEG data
    Published on 2026-03-23
    4 months ago
  • Magnetic resonance texture alterations in the caudate nucleus following 18 weeks of clozapine treatment in patients with treatment-resistant schizophrenia
    Published on 2026-03-23
    4 months ago
  • The role of the oxytocinergic system in oral microbiome composition in children with autism: evidence from a randomized controlled trial of intranasal oxytocin
    Published on 2026-03-23
    4 months ago
  • Metabotropic glutamate receptor 5 in the anterior cingulate cortex predicts individual differences in motor impulsivity but not in risky decision-making
    Published on 2026-03-22
    4 months ago
  • Longitudinal investigation of the T helper (Th)1-Th2 balance and complement system in clinical high risk for psychosis cohort
    Published on 2026-03-22
    4 months ago
  • Dynamic modeling in neurocognitive frameworks of childhood ADHD: a review of inhibitory control and reward systems
    Published on 2026-03-22
    4 months ago
« Previous 1 … 47 48 49 50 51 … 311 Next »
Molecular Psychiatry
  • Aberrant calcium signaling and neuronal activity in the L271H CACNA1D (Cav1.3) iPSC model of neurodevelopmental disease
    Published on 2026-01-08
    7 months ago
  • Shared neurogenetic architecture links adolescent neurodevelopmental deviations to adult psychopathological procrastination
    Published on 2026-01-07
    7 months ago
  • Delay discounting correlates with depression but does not predict relapse after antidepressant discontinuation
    Published on 2026-01-07
    7 months ago
  • Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy
    Published on 2026-01-06
    7 months ago
  • Comparative efficacy and safety of different surgical strategies for refractory obsessive-compulsive disorder: evidence from network meta-analysis
    Published on 2026-01-06
    7 months ago
  • Synaptic potentiation requires PARP1 activation: prevailing concepts are revisited
    Published on 2026-01-05
    7 months ago
  • RO4938581, a GABAA-α5 negative allosteric modulator rescued behavioral and EEG phenotypes of a mouse model of Dup15q syndrome
    Published on 2026-01-04
    7 months ago
« Previous 1 … 47 48 49 50 51 … 299 Next »
Nature Reviews Neuroscience
  • Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight
    Published on 2023-08-24
    3 years ago
  • A biophysical perspective on the resilience of neuronal excitability across timescales
    Published on 2023-08-24
    3 years ago
  • The transition to motherhood: linking hormones, brain and behaviour
    Published on 2023-08-23
    3 years ago
  • Cerebrospinal fluid-contacting neurons: multimodal cells with diverse roles in the CNS
    Published on 2023-08-09
    3 years ago
  • Losing sleep in heart disease
    Published on 2023-08-08
    3 years ago
  • Network models to enhance the translational impact of cross-species studies
    Published on 2023-07-31
    3 years ago
  • Planning projections
    Published on 2023-07-28
    3 years ago
« Previous 1 … 47 48 49 50 51 … 67 Next »

 

CNS Spectrum
  • Neuropsychiatric phenotypes in functional movement disorder
    Published on 2023-07-10
    3 years ago
  • Anomic suicides on rise during recently emerging crises: revisiting Durkheim’s model
    Published on 2023-07-10
    3 years ago
  • CNS volume 28 issue 3 Cover and Back matter
    Published on 2023-05-30
    3 years ago
  • CNS volume 28 issue 3 Cover and Front matter
    Published on 2023-05-30
    3 years ago
  • Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
    Published on 2023-05-23
    3 years ago
  • Borderline personality disorder and cognition: unraveling the enigma one piece at a time!
    Published on 2023-05-15
    3 years ago
  • Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income country
    Published on 2023-05-10
    3 years ago
« Previous 1 … 47 48 49 50 51 … 96 Next »
Neuropharmacology
  • Lithium Restores Inhibitory Function and Neuronal Excitability through GSK-3β Inhibition in a Bipolar Disorder-Associated Ank3 Variant Mouse Model
    Published on 2025-08-22
    11 months ago
  • Reduced activation of pain-related brain regions with lysophosphatidic acid receptor subtype-1 antagonist PIPE-791 in a nonhuman primate model of chronic peripheral neuropathy
    Published on 2025-08-22
    11 months ago
  • Antidepressant Ketamine via Oral Gavage Impairs Fear Memory, Suppresses 22 kHz Ultrasonic Vocalizations, Lowers GluN2A/B Expression, and Reduces Medial Habenula Activity in Rats
    Published on 2025-08-22
    11 months ago
  • Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder
    Published on 2025-08-22
    11 months ago
  • Ligustilide ameliorates cerebral ischemia-reperfusion injury by inhibiting NLRP3 inflammasome-dependent pyroptosis through enhancing Nrf2 signaling
    Published on 2025-08-22
    11 months ago
  • Abstinence and Extinction Drive Opposing Changes in Striatal Activity and Dopamine Signaling During Alcohol Relapse
    Published on 2025-08-21
    11 months ago
  • TIM3 attenuates morphine antinociceptive tolerance and microglial neuroinflammation by suppressing the TRAF6/NF-κB pathway in male mice
    Published on 2025-08-20
    11 months ago
« Previous 1 … 47 48 49 50 51 … 190 Next »
Nature
  • Epiblast diversification and blood formation in a human pregastrula
    Published on 2026-06-24
    1 month ago
  • Ductile alloys offering 100 MPa tensile strength at 2,400 °C
    Published on 2026-06-24
    1 month ago
  • Alternate RNA decoding results in stable and abundant proteins in mammals
    Published on 2026-06-24
    1 month ago
  • Detection of anisotropic cosmic structures on a gigaparsec scale
    Published on 2026-06-24
    1 month ago
  • An ECG biomarker for sudden cardiac death discovered with deep learning
    Published on 2026-06-24
    1 month ago
  • Author Correction: cBAF complex components and MYC cooperate early in CD8+ T cell fate
    Published on 2026-06-24
    1 month ago
  • Genetic technologies to enhance crop nutritional value under climate change
    Published on 2026-06-24
    1 month ago
« Previous 1 … 47 48 49 50 51 … 2,560 Next »

   Pharma Pub